Patents by Inventor Jung-hee Kim

Jung-hee Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210111816
    Abstract: The present disclosure provides an RSS (Received Signal Strength) signal correction method for performing location measurement by utilizing information among a plurality of nodes, and the RSS signal correction method estimates a variable of an RSS signal model based on at least one of location information of a fixed node, location information of an unknown node and measurement noise information of the unknown node.
    Type: Application
    Filed: April 30, 2020
    Publication date: April 15, 2021
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Jung Hee KIM, Doik KIM
  • Patent number: 10813954
    Abstract: The present invention relates to a pharmaceutical composition for treating diabetes, which includes a pancreatic islet cell and an elastin-like artificial extracellular matrix (REP), and more particularly, to a pharmaceutical composition for treating diabetes, in which pancreatic islet cells are reacted with an elastin-like artificial extracellular matrix and then the resulting cells are administered along with the elastin-like artificial extracellular matrix, thus increasing a survival rate of the transplanted pancreatic islet cells, rapidly restoring a blood glucose level to normal, and maintaining the restored blood glucose level for a long period of time, and, accordingly, diabetes may be more effectively treated.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: October 27, 2020
    Assignee: DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Kyeong Min Lee, Won Bae Jeon, Jung Hee Kim
  • Patent number: 10751378
    Abstract: The present invention relates to a composition for suppressing chronic obstructive pulmonary disease (COPD) comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom and, more particularly, to a pharmaceutical composition for preventing or treating COPD comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom; a food composition for preventing or improving COPD, and the compound isolated therefrom. The composition comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom, according to the present invention, is not toxic, suppresses the invasion of inflammatory cells into the bronchial tube of a COPD-induced animal model, and effectively suppresses the expression of CXCL-1, TNF-?, or MIP-2.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: August 25, 2020
    Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Sei Ryang Oh, Kyung Seop Ahn, Seung Hyung Kim, In Sik Shin, Hang Jin, Jung Hee Kim, Hyung Won Ryu, Wan Yi Li, Sang Woo Lee, Joong Ku Lee, Sang Ho Choi
  • Publication number: 20200141952
    Abstract: The present invention relates to a method for evaluating metabolic activity based on the concentrations of cortisol and its precursors and metabolites thereof in saliva collected by a swab for the measurement of adrenal steroids relating to biochemical stress evaluation and more particularly, to a method of comparing metabolic activity of physiologically different adrenal steroids by analyzing adrenal steroids including cortisol and cortisone extracted from a trace amount of saliva by mass spectrometry and evaluating the metabolic ratio between the two compounds as well as the absolute amount of each compound. Accordingly, the present invention can be utilized as an index for evaluating response to biochemical stress and related diseases by measuring the amounts of adrenal steroids including cortisol and cortisone in a trace amount of saliva collected with a swab.
    Type: Application
    Filed: April 25, 2019
    Publication date: May 7, 2020
    Inventors: Chae Lin LEE, Jung Hee KIM, Man Ho CHOI
  • Patent number: 10590905
    Abstract: The floating apparatus for wave power generation according to the present invention includes; a floating unit floating on a sea surface; an energy unit configured to convert a kinetic energy of the floating unit to an electric or hydraulic energy; and a transfer unit configured to transfer the kinetic energy of the floating unit to the energy unit.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: March 17, 2020
    Assignees: INGINE, INC.
    Inventors: Yong Jun Sung, Min Su Cho, Jung Hee Kim
  • Publication number: 20190314436
    Abstract: A composition for prevention or treatment of liver cancer includes a Nardostachys jatamansi extract. The composition exhibits anti-cancer effects on liver cancer and/or specific liver cancer resistant to antibiotics. The composition can be included, for example, in a pharmaceutical composition or a health functional food.
    Type: Application
    Filed: November 4, 2016
    Publication date: October 17, 2019
    Inventors: Sung-Yeoun HWANG, Seung-Kew YOON, Jung-Hee KIM
  • Patent number: 10413579
    Abstract: The present invention relates to a composition for preventing or treating asthma comprising a Pistacia weinmannifolia J. Poiss. ex Franch extract or a fraction thereof. The Pistacia weinmannifolia J. Poiss. ex Franch extract or the fraction thereof according to the present invention does not exhibit toxicity, inhibits the generation of NO, IL-4, IL-5, and IL-13 and the generation of reactive oxygen species in the bronchial tubes, and has significantly induced the alleviation of airway hyperresponsiveness, inhibition of the infiltration of inflammatory cells into the bronchial tubes, and reduction of inflammatory cells in bronchoalveolar lavage fluid in an ovalbumin-induced asthma mouse model. In addition, the Pistacia weinmannifolia J. Poiss.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: September 17, 2019
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Kyung Seop Ahn, Sei Ryang Oh, Ok Kyoung Kwon, In Sik Shin, Hyung Won Ryu, Sang Woo Lee, Joong Ku Lee, Hyeong Kyu Lee, Sang Ho Choi, Doo Young Kim, Jung Hee Kim, Li Wan Yi, Jin Hang
  • Patent number: 10376553
    Abstract: A pharmaceutical composition includes any of an extract of Magnoliae flos, a fraction or an active fraction obtained by fractionation thereof with an organic solvent, and a compound separated therefrom as an active ingredient. The extract of Magnoliae flos, the fraction or the active fraction obtained by fractionation thereof with an organic solvent, or the compound separated therefrom inhibits the expression of MUC5AC induced by TNF-? and the promoter activity in human lung cancer mucosal cells (H292), reduces the number of inflammatory cells in the bronchoalveolar lavage fluid of the chronic obstructive pulmonary disease mouse model, inhibits the production of reactive oxygen species, and reduces the cytokines; and therefore are effective in preventing or treating chronic obstructive pulmonary disease.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: August 13, 2019
    Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Sei-Ryang Oh, Kyung Seop Ahn, Su Ui Lee, Hyung Won Ryu, Doo-Young Kim, Hyeong Kyu Lee, Ok-Kyoung Kwon, Jung Hee Kim, Hyun-Jun Lee, In-Sik Shin
  • Patent number: 10195166
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating hepatitis C virus (HCV) infectious disease. More particularly, the present invention relates to a pharmaceutical composition for preventing or treating HCV infectious disease or an antiviral composition for HCV, containing at least one selected from the group consisting of: GRIM19 protein or a fragment thereof; and a gene encoding the protein or a fragment of the protein.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: February 5, 2019
    Assignee: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Seung Kew Yoon, Jung Hee Kim, Won Hee Hur, Mi La Cho, Jung Eun Choi, Eun Byul Lee
  • Publication number: 20180353561
    Abstract: A pharmaceutical composition includes any of an extract of Magnoliae flos, a fraction or an active fraction obtained by fractionation thereof with an organic solvent, and a compound separated therefrom as an active ingredient. The extract of Magnoliae flos, the fraction or the active fraction obtained by fractionation thereof with an organic solvent, or the compound separated therefrom inhibits the expression of MUC5AC induced by TNF-? and the promoter activity in human lung cancer mucosal cells (H292), reduces the number of inflammatory cells in the bronchoalveolar lavage fluid of the chronic obstructive pulmonary disease mouse model, inhibits the production of reactive oxygen species, and reduces the cytokines; and therefore are effective in preventing or treating chronic obstructive pulmonary disease.
    Type: Application
    Filed: May 13, 2016
    Publication date: December 13, 2018
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Sei-Ryang OH, Kyung Seop AHN, Su Ui LEE, Hyung Won RYU, Doo-Young KIM, Hyeong Kyu LEE, Ok-Kyoung KWON, Jung Hee KIM, Hyun-Jun LEE, In-Sik SHIN
  • Patent number: 10137156
    Abstract: The present invention relates to a composition including neural cells and an elastin-like polypeptide for treating Parkinson's diseases. More particularly, the present invention relates to a composition for treating Parkinson's diseases, which can more effectively increase a survival rate and settling rate of neural cells transplanted to an acutely or chronically damaged nerve region for treatment of Parkinson's disease, by simultaneously administering an elastin-like polypeptide with neural cells.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: November 27, 2018
    Assignee: DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Won Bae Jeon, Jung-Hee Kim, Kyeong-Min Lee, Seong-Kyoon Choi
  • Publication number: 20180318357
    Abstract: The present invention relates to a pharmaceutical composition for treating diabetes, which includes a pancreatic islet cell and an elastin-like artificial extracellular matrix (REP), and more particularly, to a pharmaceutical composition for treating diabetes, in which pancreatic islet cells are reacted with an elastin-like artificial extracellular matrix and then the resulting cells are administered along with the elastin-like artificial extracellular matrix, thus increasing a survival rate of the transplanted pancreatic islet cells, rapidly restoring a blood glucose level to normal, and maintaining the restored blood glucose level for a long period of time, and, accordingly, diabetes may be more effectively treated.
    Type: Application
    Filed: November 3, 2016
    Publication date: November 8, 2018
    Applicant: DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Kyeong Min LEE, Won Bae JEON, Jung Hee KIM
  • Patent number: 10053443
    Abstract: The present invention relates to a novel 2-phenylbenzofuran derivative or a pharmaceutically acceptable salt thereof, a production method for the same, and a pharmaceutical composition for preventing or treating an inflammatory disease comprising the same as an active ingredient, and the novel 2-phenylbenzofuran derivative or the pharmaceutically acceptable salt thereof according to the present invention is outstandingly effective in suppressing NO, IL-6, and TNF-alpha induced by macrophages, and therefore can advantageously be used in a pharmaceutical composition for preventing or treating an inflammatory disease.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: August 21, 2018
    Assignees: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, DONGGUK UNIVERSITY INDUSTRY—ACADEMIC COOPERATION FOUNDATION
    Inventors: Kyeong Lee, Sei-Ryang Oh, Kyung Seop Ahn, Ok-Kyoung Kwon, Doo-Young Kim, Hyung Won Ryu, Jung Hee Kim, Xuezhen Xu
  • Patent number: 10046019
    Abstract: The present invention relates to inventive novel industrialized method for preparing purified extract containing more abundant active ingredients such as catalpol derivatives from the extract of Pseudolysimachion rotundum var subintegrum than that prepared by the conventional preparation method disclosed in the prior art and the therapeutics or functional health food comprising the purified extract for treating and preventing inflammatory, allergic or asthmatic disease. The purified extract showed more potent anti-inflammatory, anti-allergy and anti-asthma activity than that prepared by the conventional preparation method disclosed in the prior art through various in vivo tests such as inhibition test on the reproduction of eosinophil, the release of immunoglobulin and inflammatory chemokines in plasma and bronchoalveolar fluid as well as the suppression of airway hyperresponsiveness and goblet cell hyperplasia in a OVA-sensitized/challenged mouse model.
    Type: Grant
    Filed: September 11, 2016
    Date of Patent: August 14, 2018
    Assignees: YUNGJIN PHARMACEUTICAL CO., LTD, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Yongnam Lee, Ji-seok Yoo, Dae-hee Shin, Byung-hwan Ryoo, Sei-ryang Oh, Kyung-seop Ahn, Hyeongkyu Lee, Ok-kyoung Kwon, Doo-young Kim, Jung-hee Kim, Hyuk-hwan Song
  • Publication number: 20180187644
    Abstract: The floating apparatus for wave power generation according to the present invention includes; a floating unit floating on a sea surface; an energy unit configured to convert a kinetic energy of the floating unit to an electric or hydraulic energy; and a transfer unit configured to transfer the kinetic energy of the floating unit to the energy unit.
    Type: Application
    Filed: March 3, 2016
    Publication date: July 5, 2018
    Applicants: INGINE, INC.
    Inventors: Yong Jun SUNG, Min Su CHO, Jung Hee KIM
  • Patent number: 9999646
    Abstract: The present invention relates to inventive novel industrialized method for preparing purified extract containing more abundant active ingredients such as catalpol derivatives from the extract of Pseudolysimachion rotundum var subintegrum than that prepared by the conventional preparation method disclosed in the prior art and the therapeutics or functional health food comprising the purified extract for treating and preventing inflammatory, allergic or asthmatic disease. The purified extract showed more potent anti-inflammatory, anti-allergy and anti-asthma activity than that prepared by the conventional preparation method disclosed in the prior art through various in vivo tests such as inhibition test on the reproduction of eosinophil, the release of immunoglobulin and inflammatory chemokines in plasma and bronchoalveolar fluid as well as the suppression of airway hyperresponsiveness and goblet cell hyperplasia in a OVA-sensitized/challenged mouse model.
    Type: Grant
    Filed: September 11, 2016
    Date of Patent: June 19, 2018
    Assignees: YUNGJIN PHARMACEUTICAL CO., LTD, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Yongnam Lee, Ji-seok Yoo, Dae-hee Shin, Byung-hwan Ryoo, Sei-ryang Oh, Kyung-seop Ahn, Hyeongkyu Lee, Ok-kyoung Kwon, Doo-young Kim, Jung-hee Kim, Hyuk-hwan Song
  • Patent number: 9895975
    Abstract: Disclosed is a bar type display apparatus which is capable of providing various information without obstructing a front view of a driver, and a vehicle comprising the same, wherein the bar type display apparatus may include a display module provided on a dashboard and disposed adjacent to a lower portion of a front glass of a vehicle, wherein the display module extends from one edge of the dashboard to the other edge of the dashboard.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: February 20, 2018
    Assignee: LG Display Co., Ltd.
    Inventors: Kyong Taik Lee, Jung Hee Kim
  • Patent number: 9851817
    Abstract: An optical touch display device which is advantageous in high-speed driving, large-area touch sensing, and multi-touch sensing because of use of an image map and which can improve touch sensing performance and a driving method thereof are provided. The optical touch display device includes a display device configured to display a display image based on input source image data and an image map for touch sensing, an optical touch pen configured to detect map information of the image map displayed on the display device, and a position detector configured to detect position information (coordinate information) on a screen based on the map information.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: December 26, 2017
    Assignee: LG Display Co., Ltd.
    Inventors: Jung Hee Kim, Ki Duk Kim, Jong Hee Hwang, Seung Seok Oh
  • Patent number: 9820963
    Abstract: The present invention relates to a pharmaceutical composition for preventing, ameliorating, or treating cancer. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating cancer including a lignan compound having a specific chemical structure (Chemical Formula 1); a health functional food composition for preventing or ameliorating cancer including the lignan compound; and a method for preventing, ameliorating, or treating cancer using the composition. Further, the present invention relates to a use of the lignan compound in the preparation of a pharmaceutical composition or a health functional food composition for preventing, ameliorating, or treating cancer.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: November 21, 2017
    Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Sei Ryang Oh, Yong Yeon Cho, Hyung Won Ryu, Cheol Jung Lee, Hye Suk Lee, Doo Young Kim, Jung Hee Kim, Kyung Seop Ahn, Mee Hyun Lee, Hyeong Kyu Lee
  • Patent number: 9696717
    Abstract: An apparatus and method of segmenting sensor data are provided. The apparatus includes a sensor, a first segmentation unit, a continuity evaluation unit, a second segmentation unit, and a segmentation determination unit. The sensor collects sensor data for a process of the semiconductor manufacturing facility. The first segmentation unit extracts a variation point of the sensor data to perform an abnormal difference (AD) segmentation on the sensor data based on the at least one variation point. The continuity evaluation unit evaluates a continuity ratio of the sensor data. The second segmentation unit performs a free-knot spline (FS) segmentation on the sensor data when the continuity ratio exceeds a reference ratio. The segmentation determination unit compares the AD segmentation result with the FS segmentation result and to select one of the results on the comparison result.
    Type: Grant
    Filed: May 16, 2014
    Date of Patent: July 4, 2017
    Assignees: SAMSUNG ELECTRONICS CO., LTD., SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
    Inventors: Hae-Sang Park, Young-Hak Lee, Jung-Hee Kim, Heui-Sik Jeon, Eunjeong Lucy Park, Sungzoon Cho, Jooseoung Park, Jiwon Yang